Endocrinology, Vol 137, 2217-2224, Copyright © 1996 by Endocrine Society

ARTICLES

Estrogen blocks parathyroid hormone (PTH)-stimulated osteoclast-like cell formation by selectively affecting PTH-responsive cyclic adenosine monophosphate pathway

H Kaji, T Sugimoto, M Kanatani, M Nasu and K Chihara
Department of Medicine, Kobe University School of Medicine, Japan.

Several lines of evidence have previously indicated that estrogen inhibits PTH-induced bone resorption in vivo and in vitro. However, its mechanism remains unknown. Therefore, the present study was performed to investigate the effect of estrogen on PTH-stimulated osteoclast-like cell formation and clarify its mechanism. 17 beta-estradiol (17 beta- E2) significantly antagonized osteoclast-like cell formation stimulated by 10(-8) M human (h) PTH-(1-34) as well as 10(-8) M hPTH-related peptide (PTHrP)-(1-34)in osteoblast-containing mouse bone cell cultures. The conditioned medium derived from osteoblastic SaOS-2 cells or MC3T3-E1 cells pretreated with both PTH-(1-34) (10(-8)M) and 17 beta- E2(10(-8)M) stimulated osteoclast-like cell formation from hemopoietic blast cells more weakly than conditioned medium from cells pretreated with PTH-(1-34) alone. Moreover, 10(-8) M 17 beta-E2 significantly blocked the formation of osteoclast-like cells stimulated by 10(-8) M hPTH-(1-34) in spleen cell cultures derived from 5-fluorouracil- pretreated mice. On the other hand, 10(-8) M 17 beta-E2 significantly inhibited osteoclast-like cell formation stimulated by dbcAMP (10(-4)M) and Sp-cAMPS (10(-4)M), as well as forskolin (10(-5)M) in mouse bone cell cultures. In contrast, 10(-8)M 17 beta-E2 did not affect PMA (10(- 7)M)-, A23187 (10(-7)M)-, or BAYK-8644 (5 x 10(-6) M)-stimulated osteoclast-like cell formation. In conclusion, the present study demonstrated that estrogen inhibits PTH-stimulated osteoclast-like cell formation by directly acting on hemopoietic blast cells as well as by indirectly acting on them via osteoblasts. The inhibitory effects of estrogen on PTH-stimulated osteoclast-like cell formation seemed to be mediated through blocking the cAMP-dependent protein kinase pathway but not by blocking calcium/protein kinase C.

This article has been cited by other articles:

				M. Homme, C. P. Schmitt, R. Himmele, G. F. Hoffmann, O. Mehls, and F. Schaefer Vitamin D and Dexamethasone Inversely Regulate Parathyroid Hormone-Induced Regulator of G Protein Signaling-2 Expression in Osteoblast-Like Cells Endocrinology, June 1, 2003; 144(6): 2496 - 2504. [Abstract] [Full Text] [PDF]

				D. A. Baker, Z.-X. Xi, H. Shen, C. J. Swanson, and P. W. Kalivas The Origin and Neuronal Function of In Vivo Nonsynaptic Glutamate J. Neurosci., October 15, 2002; 22(20): 9134 - 9141. [Abstract] [Full Text] [PDF]

				B.-Y. Liu, P.-W. Wu, F. R. Bringhurst, and J.-T. Wang Estrogen Inhibition of PTH-Stimulated Osteoclast Formation and Attachment in Vitro: Involvement of Both PKA and PKC Endocrinology, February 1, 2002; 143(2): 627 - 635. [Abstract] [Full Text] [PDF]

				B.-Y. Liu, J. Guo, B. Lanske, P. Divieti, H. M. Kronenberg, and F. R. Bringhurst Conditionally Immortalized Murine Bone Marrow Stromal Cells Mediate Parathyroid Hormone-Dependent Osteoclastogenesis in Vitro Endocrinology, April 1, 1998; 139(4): 1952 - 1964. [Abstract] [Full Text] [PDF]

				C. Schiller, R. Gruber, K. Redlich, G.-M. Ho, F. Katzgraber, M. Willheim, P. Pietschmann, and M. Peterlik 17{beta}-Estradiol Antagonizes Effects of 1{alpha},25-Dihydroxyvitamin D3 on Interleukin-6 Production and Osteoclast-Like Cell Formation in Mouse Bone Marrow Primary Cultures Endocrinology, November 1, 1997; 138(11): 4567 - 4571. [Abstract] [Full Text] [PDF]

				T. L. McCarthy, C. Ji, H. Shu, S. Casinghino, K. Crothers, P. Rotwein, and M. Centrella 17beta -Estradiol Potently Suppresses cAMP-induced Insulin-like Growth Factor-I Gene Activation in Primary Rat Osteoblast Cultures J. Biol. Chem., July 18, 1997; 272(29): 18132 - 18139. [Abstract] [Full Text] [PDF]